Sinovac

Haidian, China Founded: 2001 • Age: 25 yrs Acquired By SAIF Partners
Vaccines against various infectious diseases are developed by Sinovac.
Request Access

About Sinovac

Sinovac is a company based in Haidian (China) founded in 2001 was acquired by SAIF Partners in June 2017.. Sinovac operates in a competitive market with competitors including Adaptive Biotechnologies, Moderna, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others.

  • Headquarter Haidian, China
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $515 M (USD), Post-IPO

    Dec 07, 2020

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    SAIF Partners

    (Jun 26, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Sinovac

  • Total Funding
  • Total Rounds 7
  • Last Round Post-IPO — $515.0M
  • First Round

    (23 Feb 2004)

  • Investors Count 4
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2020 Amount Post-IPO - Sinovac Valuation

investors

May, 2020 Amount Post-IPO - Sinovac Valuation

investors

Jul, 2018 Amount Post-IPO - Sinovac Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Sinovac

Sinovac has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Sino Biopharmaceutical, Advantech Capital and Vivo Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Venture capital and private equity firm
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Sinovac

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Sinovac

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Sinovac Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Sinovac

Sinovac operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adaptive Biotechnologies, Moderna, Generate Biomedicines, HOOKIPA Pharma and Brii Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Clinical diagnostics and drug discovery for immune diseases are provided.
domain founded_year HQ Location
mRNA-based therapeutics for diseases including cancer and infections are developed.
domain founded_year HQ Location
Developer of novel protein-based therapeutics using machine learning and biological engineering
domain founded_year HQ Location
Developer of immunotherapies for the treatment of infectious diseases and cancer
domain founded_year HQ Location
Developer of biologics to treat hepatitis B infection
domain founded_year HQ Location
VBI Vaccines is engaged in developing vaccines and immunotherapeutics.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Sinovac

Frequently Asked Questions about Sinovac

When was Sinovac founded?

Sinovac was founded in 2001 and raised its 1st funding round 3 years after it was founded.

Where is Sinovac located?

Sinovac is headquartered in Haidian, China. It is registered at Haidian, Beijing, China.

What does Sinovac do?

Sinovac was established in 2001 in Haidian, China, within the biotechnology sector focused on vaccine development. Vaccines have been produced for hepatitis A and B, seasonal influenza, H5N1 avian flu, H1N1 swine flu, mumps, and canine rabies. The Panflu.1 H1N1 vaccine was manufactured for the Chinese Central Government. Ongoing efforts include pipeline vaccines for enterovirus 71, pneumococcal conjugate and polysaccharides, and rubella, addressing key public health needs.

Who are the top competitors of Sinovac?

Sinovac's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.

Who are Sinovac's investors?

Sinovac has 6 investors. Key investors include Sino Biopharmaceutical, Advantech Capital, Vivo Capital, Ministry of Science and Technology of the People's Republic of China, and CBC Group.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available